ZIVO Bioscience, Inc. (NASDAQ:ZIVO - Get Free Report)'s share price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $17.12 and traded as high as $20.45. ZIVO Bioscience shares last traded at $20.45, with a volume of 1,824 shares changing hands.
ZIVO Bioscience Trading Up 2.6 %
The stock has a market capitalization of $72.60 million, a price-to-earnings ratio of -3.89 and a beta of 0.24. The stock's 50 day moving average is $17.12 and its two-hundred day moving average is $11.29.
ZIVO Bioscience (NASDAQ:ZIVO - Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($2.78) EPS for the quarter.
ZIVO Bioscience Company Profile
(
Get Free Report)
ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.
Featured Stories
Before you consider ZIVO Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZIVO Bioscience wasn't on the list.
While ZIVO Bioscience currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
